126145-99-1 Usage
General Description
4-(4-Bromo-benzenesulfonylamino)-benzoic acid is a chemical compound with the molecular formula C13H10BrNO4S. It is a derivative of benzoic acid and contains a sulfonamide group. 4-(4-BROMO-BENZENESULFONYLAMINO)-BENZOIC ACID has potential applications in the field of medicinal chemistry, particularly as a building block for the synthesis of various pharmaceutical agents. It may also have uses in organic synthesis and as a reagent in chemical reactions. Due to its structural features, 4-(4-Bromo-benzenesulfonylamino)-benzoic acid has the potential to interact with biological targets and may exhibit pharmacological activity. Its properties and potential uses make it a compound of interest to researchers in various fields of science and technology.
Check Digit Verification of cas no
The CAS Registry Mumber 126145-99-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,6,1,4 and 5 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 126145-99:
(8*1)+(7*2)+(6*6)+(5*1)+(4*4)+(3*5)+(2*9)+(1*9)=121
121 % 10 = 1
So 126145-99-1 is a valid CAS Registry Number.
InChI:InChI=1/C13H10BrNO4S/c14-10-3-7-12(8-4-10)20(18,19)15-11-5-1-9(2-6-11)13(16)17/h1-8,15H,(H,16,17)/p-1
126145-99-1Relevant articles and documents
Bio-potent sulfonamides
Dineshkumar, Selvakumar,Thirunarayanan, Ganesamoorthy
, p. 4386 - 4391 (2019)
Some 4-(substituted phenylsulfonamido)benzoic acids have been synthesized by fly-ash:H3PO3 nano catalyst catalyzed condensation of substituted benzenesulfonyl chlorides and 4-aminobenzoic acid in ultrasound irradiation conditions. The yields of the sulfonamides are more than 90%. The synthesized 4-(substituted phenylsulfonamido) benzoic acid derivatives were characterized by their physical constants, analytical and spectroscopic data. Antimicrobial activities of all sulfonamides were measured by Bauer-Kirby disc diffusion method.
Design, synthesis and biological evaluation of novel non-peptide boronic acid derivatives as proteasome inhibitors
Zhang, Jiankang,Shen, Luqing,Wang, Jincheng,Luo, Peihua,Hu, Yongzhou
, p. 38 - 45 (2014/01/17)
A series of novel non-peptide boronic acid derivatives were designed and synthesized via rational drug design principles. All target compounds were screened for the proteasome inhibitory activities in vitro. Selected compounds (6a and 7j) were evaluated f
